Steve Cockrill is the founder of SLC BioPharma Consulting and brings over
20 years of biotherapeutic commercialization experience from first-in-human through licensure and post-marketing filing support.
Our core expertise is the advancement of various product modalities including traditional biologics (recombinant glycoproteins, monoclonal antibodies,
Fc-fusion proteins) from mammalian and microbial expression systems,
gene therapies (PEGylated antisense oligonucleotides), and
microbiome-based live bacterial therapeutics. Additionally, we have supported analytical needs for cell therapy programs.
In addition, we are pleased to add dedicated support for portfolio, program, and project management to our consultancy offerings. Our expert brings global experience spanning drug, device, and CMC analytical and process applications.
